WHAT'S NEXT
This is by no means an exhaustive list of sectors that could be impacted by GLP-1 usage.
Gyms and other fitness outlets, manufacturers of fitness trackers and wellness monitoring devices are all part of the mix to benefit. Other sectors like tobacco and gambling may face new challenges as cravings subside, as the drugs have shown potential to reduce urges to engage in these activities.
The call now is for nearly all businesses to ask themselves if they need to factor in the potential impact of the GLP-1 era. In conclusion, the landscape of obesity management is evolving rapidly, driven by the introduction of these game-changing medications.
Stakeholders in various industries must adapt, and proactively, to stay ahead of the curve. The future promises both challenges and opportunities, and those who are prepared will be best positioned to capitalize on this transformative shift.
Want to dive in deeper?
Revisit our recorded panel discussion with Ipsos experts to learn more:
How could altered appetites shift shopping patterns, impulse buys, and other impulsive behavior?
How can consumer goods companies collaborate with healthcare providers, dietitians, and other stakeholders to support patients using GLP-1s?
What additional GLP-1s applications will emerge, and how will those uses influence your business?
Watch Our Webinar
Join healthcare, innovation, and foresight experts from across Ipsos as they share crucial insights on how GLP-1 drugs could reshape society.
Want more?
Jackie Ilacqua
President, Global Syndicated Healthcare
Philip Ryan
Managing Partner, Ipsos Strategy3
Alyson Heffernan
Senior Vice President, Innovation
Reach out to Ipsos experts for more
Reach out to the Ipsos experts cited within this article or to your Ipsos account representative, or InsightstoActivate@ipsos.com